Chimerix reported $293.88M in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Ardelyx ARDX:US USD 144.67M 13.06M
Chimerix CMRX:US USD 293.88M 240.32M
Curis CRIS:US USD 122.85M 5.98M
Dynavax Technologies DVAX:US USD 999.34M 23.66M
Emergent Biosolutions EBS:US USD 2.91B 173.1M
Gilead Sciences GILD:US USD 62.56B 313M
Glaxosmithkline GSK:US GBP 60.31B 28.73B
Life Technologies LIFE:US USD 96.06M 39K
Merk MRK:US USD 107.08B 14M
Mirati Therapeutics MRTX:US USD 1.3B 23.29M
Novavax NVAX:US USD 2.27B 355.56M
Xoma XOMA:US USD 146.13M 8.09M